MDS Podcast https://www.movementdisorders.org Stay up to date on novel, clinically-relevant research findings in Parkinson's disease and other movement disorders. Each episode of the International Parkinson and Movement Disorder Society podcast discusses a relevant development in the field, including highlighted journal articles and interviews with the authors. International Parkinson and Movement Disorder Society webupdates@movementdisorders.org International Parkinson and Movement Disorder Society webupdates@movementdisorders.org International Parkinson and Movement Disorder Society International Parkinson and Movement Disorder Society Stay up to date on novel, clinically-relevant research findings in Parkinson's disease and other movement disorders. Each episode of the International Parkinson and Movement Disorder Society podcast discusses a relevant development in the field, including highlighted journal articles and interviews with the authors. False en-us Copyright 2022 MDS Podcast RSS Feed, International Parkinson and Movement Disorder Society https://www.movementdisorders.org/Podcast-RSS-Feed.htm Acetylcholine nuclei atrophy predicts gait changes in Parkinson's disease Dr. Michele Matarazzo interviews Dr. Nicola Ray on a recently published article that demonstrates a relationship between changes in cholinergic nuclei in MRI and future gait disorders in Parkinson's disease. <a href=" https://doi.org/10.1002/mds.28453/">Read the article</a> Dr. Michele Matarazzo interviews Dr. Nicola Ray on a recently published article that demonstrates a relationship between changes in cholinergic nuclei in MRI and future gait disorders in Parkinson's disease. <a href=" https://doi.org/10.1002/mds.28453/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/AcetylcholineNucleiAtrophyPredictsGaitChangesinParkinsonsDisease_2021_March.mp3?version=new https://www.movementdisorders.org/MDS-Files1/Podcasts/AcetylcholineNucleiAtrophyPredictsGaitChangesinParkinsonsDisease_2021_March.mp3?version=new Acetylcholine nuclei atrophy predicts gait changes in Parkinson's disease 821 No Mon, 01 Mar 2021 00:00:00 EST Advanced therapies for Parkinson's disease: Are they all the same? Dr. K. Ray Chaudhuri discusses with Dr. Michele Matarazzo his article on the differences between subthalamic nucleus DBS, intrajejunal levodopa and apomorphine infusion in Parkinson's, published in the March 2019 issue of the <i>Movement Disorders</i> journal. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.27626/">Read the article</a> Dr. K. Ray Chaudhuri discusses with Dr. Michele Matarazzo his article on the differences between subthalamic nucleus DBS, intrajejunal levodopa and apomorphine infusion in Parkinson's, published in the March 2019 issue of the <i>Movement Disorders</i> journal. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.27626/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/About/MP3-Files/AdvancedtherapiesforParkinsonsdiseasearetheyallthesame__2019_Episode3.mp3 https://www.movementdisorders.org/MDS-Files1/About/MP3-Files/AdvancedtherapiesforParkinsonsdiseasearetheyallthesame__2019_Episode3.mp3 Advanced therapies for Parkinson's disease: Are they all the same? 1220 No Fri, 22 Mar 2019 00:00:00 EST An interview with Claudia Trenkwalder | Congress 2021 Dr. Sara Schaefer discusses with Dr. Claudia Trenkwalder the 2021 Virtual MDS Congress, her tenure as the MDS president, and her hopes for the future of the MDS. Dr. Sara Schaefer discusses with Dr. Claudia Trenkwalder the 2021 Virtual MDS Congress, her tenure as the MDS president, and her hopes for the future of the MDS. https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSPodcastSpecialIssueTrenkwalderSept2021.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSPodcastSpecialIssueTrenkwalderSept2021.mp3 An interview with Claudia Trenkwalder | Congress 2021 884 No Thu, 30 Sep 2021 00:00:00 EST Antibiotics and Parkinson's disease In this issue Dr. Filip Sheperjans shares the results of the article published in the March 2020 issue of the <i>Movement Disorders</i> journal on the effect of antibiotic exposure on the risk of developing Parkinson's disease. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mds.27924/">Read the article</a> In this issue Dr. Filip Sheperjans shares the results of the article published in the March 2020 issue of the <i>Movement Disorders</i> journal on the effect of antibiotic exposure on the risk of developing Parkinson's disease. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mds.27924/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/AntibioticsandParkinsonsdiseasearetheyrelated__2020_March.mp3 https://movementdisorders.org/MDS-Files1/Podcasts/AntibioticsandParkinsonsdiseasearetheyrelated__2020_March.mp3 Antibiotics and Parkinson's disease 1284 No Tue, 31 Mar 2020 00:00:00 EST Anti-inflammatory drugs use impacts the risk of developing PD in LRRK2 mutation carriers Dr. Marta San Luciano shares the main findings of the recently published article on the impact of non-steroidal anti-inflammatory drugs use on the risk of developing PD in a large LRRK2 mutation carriers cohort. <a href=" https://doi.org/10.1002/mds.28189/">Read the article</a> Dr. Marta San Luciano shares the main findings of the recently published article on the impact of non-steroidal anti-inflammatory drugs use on the risk of developing PD in a large LRRK2 mutation carriers cohort. <a href=" https://doi.org/10.1002/mds.28189/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/Anti-inflammatorydrugsuseimpactstheriskofdevelopingPDinLRRK2mutationcarriers_2020_September.mp3 https://movementdisorders.org/MDS-Files1/Podcasts/Anti-inflammatorydrugsuseimpactstheriskofdevelopingPDinLRRK2mutationcarriers_2020_September.mp3 Anti-inflammatory drugs use impacts the risk of developing PD in LRRK2 mutation carriers 636 No Mon, 09 Nov 2020 00:00:00 EST Anxiety in parkinson's disease and its correlates in mri-based functional connectivity Dr. Michele Matarazzo interviews Dr. Rosa De Micco on the functional MRI correlates of anxiety in Parkinson's disease, highlighting the main results of the article she recently published on the topic in the <i>Movement Disorders</i> journal.<a href=" https://doi.org/10.1002/mds.28372">Read the article</a> Dr. Michele Matarazzo interviews Dr. Rosa De Micco on the functional MRI correlates of anxiety in Parkinson's disease, highlighting the main results of the article she recently published on the topic in the <i>Movement Disorders</i> journal.<a href=" https://doi.org/10.1002/mds.28372">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/AnxietyinParkinsonsdiseaseanditscorrelatesinMRI-basedfunctionalconnectivity_2021_February.mp3?version=new https://www.movementdisorders.org/MDS-Files1/Podcasts/AnxietyinParkinsonsdiseaseanditscorrelatesinMRI-basedfunctionalconnectivity_2021_February.mp3?version=new Anxiety in parkinson's disease and its correlates in mri-based functional connectivity 540 No Mon, 01 Feb 2021 00:00:00 EST Approach to neuroimaging in Parkinsonisms Dr. Sara Schaefer discusses with Professor Antonio Strafella and Dr. Cecilia Peralta their work from the MDS Neuroimaging Study Group published in <i>Movement Disorders Clinical Practice</i> on a "Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms." <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/abs/10.1002/mdc3.13354/">Read the article</a> Dr. Sara Schaefer discusses with Professor Antonio Strafella and Dr. Cecilia Peralta their work from the MDS Neuroimaging Study Group published in <i>Movement Disorders Clinical Practice</i> on a "Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms." <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/abs/10.1002/mdc3.13354/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/ApproachtoNeuroimaginginParkinsonisms-Jan2022MDSPodcast.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/ApproachtoNeuroimaginginParkinsonisms-Jan2022MDSPodcast.mp3 Approach to neuroimaging in Parkinsonisms 21:21 No Mon, 17 Jan 2022 00:00:00 EST Approach to reviewing a review article For the sixth episode of the special series focused on the peer review process, Dr. Shweta Prasad speaks with Prof. Christine Klein to discuss the approach to reviewing a review article. For the sixth episode of the special series focused on the peer review process, Dr. Shweta Prasad speaks with Prof. Christine Klein to discuss the approach to reviewing a review article. https://www.movementdisorders.org/MDS-Files1/Podcasts/Pod64_PeerReview6.mp3 http://movementdisorders.org/Podcasts/Approach-to-reviewing-a-review-article.htm Approach to reviewing a review article 11:35 no Mon, 16 May 2022 00:00:00 EST Atypical Parkinsonisms | Congress 2019 As part of the MDS Congress 2019 Special Issue, Dr. Michele Matarazzo interviews Dr. Gesine Respondek about atypical parkinsonisms, focusing on the MDS activities to advance in the knowledge and management of these diseases and facilitate clinical trials. As part of the MDS Congress 2019 Special Issue, Dr. Michele Matarazzo interviews Dr. Gesine Respondek about atypical parkinsonisms, focusing on the MDS activities to advance in the knowledge and management of these diseases and facilitate clinical trials. https://www.movementdisorders.org/MDS-Files1/About/MP3-Files/MDSCongress2019SpecialIssue_Atypicalparkinsonisms_2019_October.mp3 https://www.movementdisorders.org/MDS-Files1/About/MP3-Files/MDSCongress2019SpecialIssue_Atypicalparkinsonisms_2019_October.mp3 Atypical Parkinsonisms | Congress 2019 282 No Wed, 06 Nov 2019 00:00:00 EST Autophagy in levodopa-induced dyskinesia: A new potential therapeutic target Dr. Michele Matarazzo interviews Prof. Gilberto Fisone about the role of autophagy in levodopa-induced dyskinesia. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.28480/">Read the article</a> Dr. Michele Matarazzo interviews Prof. Gilberto Fisone about the role of autophagy in levodopa-induced dyskinesia. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.28480/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/AutophagyinLevodopa-InducedDyskinesia.Anewpotentialtherapeutictarget__2021_May.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/AutophagyinLevodopa-InducedDyskinesia.Anewpotentialtherapeutictarget__2021_May.mp3 Autophagy in levodopa-induced dyskinesia. A new potential therapeutic target 935 No Sat, 01 May 2021 00:00:00 EST Bilateral focused ultrasound thalamotomy for essential tremor, is it safe? Prof. Andres Lozano shares the results of the phase 2 clinical trial showing safety and feasibility of the staged bilateral MR-guided focus ultrasound thalamotomy in 10 patients. <a href="https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.28716?af=R">Read the article.</a> Prof. Andres Lozano shares the results of the phase 2 clinical trial showing safety and feasibility of the staged bilateral MR-guided focus ultrasound thalamotomy in 10 patients. <a href="https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.28716?af=R">Read the article.</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/PodEdp-56_Bilateralfocusedultrasoundthalamotomyforessentialtremorisitsafe.mp3 https://www.movementdisorders.org/Podcasts/Bilateral-focused-ultrasound-thalamotomy-for-essential-tremor-is-it-safe.htm Bilateral focused ultrasound thalamotomy for essential tremor, is it safe? 11:49 no Mon, 14 Mar 2022 00:00:00 EST Blinded RT-QuIC analysis of alpha-synuclein biomarker in skin tissue from Parkinson's disease patients Dr. Sara Schaefer speaks with Dr. Anumantha Kanthasamy about RT-QuIC from skin tissues as a potential new biomarker for Parkinson's disease. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.28242/">Read the article</a> Dr. Sara Schaefer speaks with Dr. Anumantha Kanthasamy about RT-QuIC from skin tissues as a potential new biomarker for Parkinson's disease. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.28242/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSPodcastSpecialIssueResearchAOT2021.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSPodcastSpecialIssueResearchAOT2021.mp3 Blinded RT-QuIC analysis of alpha-synuclein biomarker in skin tissue from Parkinson's disease patients 846 No Wed, 01 Sep 2021 00:00:00 EST Cognitive and visuospatial abilities in dystonia Dr. Sara Schaefer speaks with Dr. Carlos Camargo about the non-motor and prodromal features of dystonia. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/epdf/10.1002/mdc3.13259/">Read the article</a> Dr. Sara Schaefer speaks with Dr. Carlos Camargo about the non-motor and prodromal features of dystonia. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/epdf/10.1002/mdc3.13259/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSPodcastJune2021.m4a https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSPodcastJune2021.m4a Cognitive and visuospatial abilities in dystonia 1045 No Tue, 01 Jun 2021 00:00:00 EST Deep brain stimulation for Parkinson, beyond motor improvement: Social and occupational outcomes In this interview, Prof. Günther Deuschl highlights the main results of the EARLYSTIM project, focusing on non-motor outcomes, and especially on the effects of DBS on Social and Occupational Functioning in Parkinson's Disease. <a href=" https://doi.org/10.1002/mdc3.13015">Read the article</a> In this interview, Prof. Günther Deuschl highlights the main results of the EARLYSTIM project, focusing on non-motor outcomes, and especially on the effects of DBS on Social and Occupational Functioning in Parkinson's Disease. <a href=" https://doi.org/10.1002/mdc3.13015">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/DeepBrainStimulationforParkinsonbeyondmotorimprovement_SocialandOccupationaloutcomes.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/DeepBrainStimulationforParkinsonbeyondmotorimprovement_SocialandOccupationaloutcomes.mp3 beyond motor improvement: Social and occupational outcomes, Deep brain stimulation for Parkinson 1044 No Tue, 22 Sep 2020 00:00:00 EST Definition and characteristics of early onset PSP: A different disease? In this interview with Dr. Edwin Jabbari, we highlight the results of his study on the definition and genetic and neuropathological characteristics of early onset progressive supranuclear palsy. The full study is available on the September 2019 issue of the <i>Movement Disorders</i> journal. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.27786/">Read the article</a> In this interview with Dr. Edwin Jabbari, we highlight the results of his study on the definition and genetic and neuropathological characteristics of early onset progressive supranuclear palsy. The full study is available on the September 2019 issue of the <i>Movement Disorders</i> journal. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.27786/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/DefinitionandcharacteristicsofearlyonsetPSP_adifferentdisease_.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/DefinitionandcharacteristicsofearlyonsetPSP_adifferentdisease_.mp3 Definition and characteristics of early onset PSP: A different disease? 865 No Mon, 14 Oct 2019 00:00:00 EST Does glucocerebrosidase activity correlate with disease risk or phenotype severity in Parkinson's disease? A discussion with Dr. Avner Thaler on the findings and implications of a study on the background of importance of GBA mutations and GCase activity in Parkinson's disease. <a href="https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mds.28792">Read the Article. </a> A discussion with Dr. Avner Thaler on the findings and implications of a study on the background of importance of GBA mutations and GCase activity in Parkinson's disease. <a href="https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mds.28792">Read the Article. </a> https://www.movementdisorders.org/MDS-Files1/Podcasts/Pod-59-DoesglucocerebrosidaseactivitycorrelatewithdiseaseriskorphenotypeseverityinParkinsonsdisease.mp3 https://movementdisorders.org/MDS-Files1/Podcasts/Pod-59-DoesglucocerebrosidaseactivitycorrelatewithdiseaseriskorphenotypeseverityinParkinsonsdisease.mp3 Does glucocerebrosidase activity correlate with disease risk or phenotype severity in Parkinson's disease? 16:38 no Mon, 11 Apr 2022 00:00:00 EST Dystonia | Congress 2019 As part of the MDS Congress 2019 Special Issue, Dr. Sara Schaefer interviews Dr. Hyder Jinnah about notable research in dystonia and activities of the MDS Dystonia Study Group. As part of the MDS Congress 2019 Special Issue, Dr. Sara Schaefer interviews Dr. Hyder Jinnah about notable research in dystonia and activities of the MDS Dystonia Study Group. https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSCongress2019Dystonia.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSCongress2019Dystonia.mp3 Dystonia | Congress 2019 306 No Thu, 24 Oct 2019 00:00:00 EST Education at the MDS | Congress 2019 As part of the MDS Congress 2019 Special Issue, Dr. Sara Schaefer interviews Dr. Ronald Postuma about all of the educational offerings through the MDS, as well as new projects of the MDS Education Committee. As part of the MDS Congress 2019 Special Issue, Dr. Sara Schaefer interviews Dr. Ronald Postuma about all of the educational offerings through the MDS, as well as new projects of the MDS Education Committee. https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSCongress2019EducationFinal.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSCongress2019EducationFinal.mp3 Education at the MDS | Congress 2019 422 No Fri, 18 Oct 2019 00:00:00 EST Electroconvulsive therapy in movement disorders Dr. Sara Schaefer discusses with Dr. Pedro Garcia Ruiz his recent paper in <i>Movement Disorders Clinical Practice</i> discussing the history and data behind the use of electroconvulsive therapy in Parkinson's disease and other movement disorders. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mdc3.13180/">Read the article</a> Dr. Sara Schaefer discusses with Dr. Pedro Garcia Ruiz his recent paper in <i>Movement Disorders Clinical Practice</i> discussing the history and data behind the use of electroconvulsive therapy in Parkinson's disease and other movement disorders. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mdc3.13180/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/Electroconvulsivetherapyinmovementdisorders_2021_April.m4a?version=new https://www.movementdisorders.org/MDS-Files1/Podcasts/Electroconvulsivetherapyinmovementdisorders_2021_April.m4a?version=new Electroconvulsive therapy in movement disorders 1076 No Thu, 01 Apr 2021 00:00:00 EST Fine tuning DBS in Parkinson's disease. How much can we improve? Dr. Viswas Dayal discusses with Dr. Michele Matarazzo how adjusting the pulse width of deep brain stimulation could impact Parkinson's disease, highlighting the results of the paper he recently published in the <i>Movement Disorders</i> journal. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mds.27863/">Read the article</a> Dr. Viswas Dayal discusses with Dr. Michele Matarazzo how adjusting the pulse width of deep brain stimulation could impact Parkinson's disease, highlighting the results of the paper he recently published in the <i>Movement Disorders</i> journal. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mds.27863/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/FinetuningDBSinParkinsonsdisease.Howmuchcanweimprove.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/FinetuningDBSinParkinsonsdisease.Howmuchcanweimprove.mp3 Fine tuning DBS in Parkinson's disease. How much can we improve? 931 No Fri, 07 Feb 2020 00:00:00 EST How to manage Parkinson's disease and related disorders, and is there a link between COVID and PD? Dr. Michele Matarazzo interviews Prof. Angelo Antonini on the effect of the COVID-19 pandemic on Parkinson's disease and other movement disorders patients and how to manage them. And also, what is the evidence of a link between COVID-19 and Parkinson's disease? <a href=" https://onlinelibrary.wiley.com/doi/abs/10.1002/mds.28104/">Read the article</a> Dr. Michele Matarazzo interviews Prof. Angelo Antonini on the effect of the COVID-19 pandemic on Parkinson's disease and other movement disorders patients and how to manage them. And also, what is the evidence of a link between COVID-19 and Parkinson's disease? <a href=" https://onlinelibrary.wiley.com/doi/abs/10.1002/mds.28104/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/MovementDisordersintimesofCOVID-19_HowtomanageParkinsonsdiseaseandrelateddisordersandistherealinkbetweenCOVIDandPD_.mp3 http://movementdisorders.org/MDS-Files1/Podcasts/MovementDisordersintimesofCOVID-19_HowtomanageParkinsonsdiseaseandrelateddisordersandistherealinkbetweenCOVIDandPD_.mp3 and is there a link between COVID and PD?, How to manage Parkinson's disease and related disorders 1466 No Mon, 18 May 2020 00:00:00 EST How to review an original scientific article For this episode of our special series focused on the peer review process, Dr. Alana Kirby speaks with Dr. Tony Lang about how to approach reviewing an original scientific article. For this episode of our special series focused on the peer review process, Dr. Alana Kirby speaks with Dr. Tony Lang about how to approach reviewing an original scientific article. https://www.movementdisorders.org/MDS-Files1/Podcasts/Pod-ep-62_Peer-Review-5.mp3 http://movementdisorders.org/Podcasts/How-to-review-an-original-scientific-article.htm How to review an original scientific article 15:46 no Mon, 02 May 2022 00:00:00 EST Huntington's disease | Congress 2019 As part of the MDS Congress 2019 Special Issue, Dr. Schaefer and Dr. Sarah Tabrizi discuss the evolving research in disease-modifying therapies for Huntington's Disease, and what may come next. <a href=" /">Read the article</a> As part of the MDS Congress 2019 Special Issue, Dr. Schaefer and Dr. Sarah Tabrizi discuss the evolving research in disease-modifying therapies for Huntington's Disease, and what may come next. <a href=" /">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSCongress2019HD.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSCongress2019HD.mp3 Huntington's disease | Congress 2019 373 No Wed, 23 Oct 2019 00:00:00 EST Infectious agents as drivers of synucleinopathies? Dr. Tiago Outeiro interviews Dr. Morgane Linard about the recently published article, "Infectious Agents as Potential Drivers of α-Synucleinopathies." <a href="https://movementdisorders.onlinelibrary.wiley.com/doi/abs/10.1002/mds.28925">Read the Article.</a> Dr. Tiago Outeiro interviews Dr. Morgane Linard about the recently published article, "Infectious Agents as Potential Drivers of α-Synucleinopathies." <a href="https://movementdisorders.onlinelibrary.wiley.com/doi/abs/10.1002/mds.28925">Read the Article.</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/PodEp-61-infectious-agents-synucleinopathies.mp3 http://movementdisorders.org/Podcasts/Infectious-agents-as-drivers-of-synucleinopathies.htm Infectious agents as drivers of synucleinopathies? 14:45 no Mon, 25 Apr 2022 00:00:00 EST Integrated therapy for functional movement disorders Dr. Sara Schaefer discusses with Dr. Sarah Lidstone her recent paper in <i>Movement Disorders Clinical Practice</i> about a novel, multidisciplinary therapeutic intervention for functional movement disorders patients. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mdc3.12888/">Read the article</a> Dr. Sara Schaefer discusses with Dr. Sarah Lidstone her recent paper in <i>Movement Disorders Clinical Practice</i> about a novel, multidisciplinary therapeutic intervention for functional movement disorders patients. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mdc3.12888/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSPodcastFeb2020.mp3 https://movementdisorders.org/MDS-Files1/Podcasts/MDSPodcastFeb2020.mp3 Integrated therapy for functional movement disorders 999 No Fri, 21 Feb 2020 00:00:00 EST Interview with Dr. Jon Stoessl on Preprints in the COVID-Era Preprint articles of scientific results have been thrust into the spotlight due to the desire for rapid results pertaining to COVID-19. Here, we dive into the trend with <i>Movement Disorders’</i> editor, Dr. Jon Stoessl. <a href=" https://www.movementdisorders.org/MDS/News/MDS-Community-Conversations/Interview-with-Dr.-Jon-Stoessl-on-Preprints-in-the-COVID-Era.htm/">Read the article</a> Preprint articles of scientific results have been thrust into the spotlight due to the desire for rapid results pertaining to COVID-19. Here, we dive into the trend with <i>Movement Disorders’</i> editor, Dr. Jon Stoessl. <a href=" https://www.movementdisorders.org/MDS/News/MDS-Community-Conversations/Interview-with-Dr.-Jon-Stoessl-on-Preprints-in-the-COVID-Era.htm/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/JonStoesslInterview2.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/JonStoesslInterview2.mp3 Interview with Dr. Jon Stoessl on Preprints in the COVID-Era 17:32 No Sun, 20 Sep 2020 00:00:00 EST Interview with the president on the MDS activities during the COVID crisis In this interview the president of the MDS, Prof. Claudia Trenkwalder shares the main changes and strategies that the MDS is implementing to adapt to the COVID-19 pandemic, including the replacement of the International MDS congress with a virtual meeting. In this interview the president of the MDS, Prof. Claudia Trenkwalder shares the main changes and strategies that the MDS is implementing to adapt to the COVID-19 pandemic, including the replacement of the International MDS congress with a virtual meeting. https://www.movementdisorders.org/MDS-Files1/Podcasts/MovementDisordersintimesofCOVID-19_interviewwiththepresidentontheMDSactivitiesduringtheCOVIDcrisis.mp3 https://movementdisorders.org/MDS-Files1/Podcasts/MovementDisordersintimesofCOVID-19_interviewwiththepresidentontheMDSactivitiesduringtheCOVIDcrisis.mp3 Interview with the president on the MDS activities during the COVID crisis 842 No Tue, 26 May 2020 00:00:00 EST Introduction and functional movement disorders | Congress 2019 Did you miss the MDS Congress in Nice, or do you just want an overview of highlights from the International Congress as well as a look forward at new ventures? Dr. Schaefer introduces the MDS Congress 2019 special issue, which features interviews with experts in various fields of movement disorders at the MDS Congress 2019. In this first issue, Dr. Sara Schaefer interviews Dr. Kathrin LaFaver about notable research in functional movement disorders, activities of the MDS Functional Movement Disorders Study Group, and more. Did you miss the MDS Congress in Nice, or do you just want an overview of highlights from the International Congress as well as a look forward at new ventures? Dr. Schaefer introduces the MDS Congress 2019 special issue, which features interviews with experts in various fields of movement disorders at the MDS Congress 2019. In this first issue, Dr. Sara Schaefer interviews Dr. Kathrin LaFaver about notable research in functional movement disorders, activities of the MDS Functional Movement Disorders Study Group, and more. https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSCongress2019IntroandFunctionalFinal.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSCongress2019IntroandFunctionalFinal.mp3 Introduction and functional movement disorders | Congress 2019 389 No Fri, 18 Oct 2019 00:00:00 EST Iron imaging of substantia nigra in Parkinson's disease: A possible biomarker? Dr. Niels Bergsland discusses with Dr. Michele Matarazzo the results of the article he recently published in the <i>Movement Disorders</i> journal on longitudinal iron imaging in the substantia nigra in PD and in its different regions. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.27730/">Read the article</a> Dr. Niels Bergsland discusses with Dr. Michele Matarazzo the results of the article he recently published in the <i>Movement Disorders</i> journal on longitudinal iron imaging in the substantia nigra in PD and in its different regions. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.27730/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/IronimagingofsubstantianigrainParkinsonsdiseaseapossiblebiomarker__2019_July.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/IronimagingofsubstantianigrainParkinsonsdiseaseapossiblebiomarker__2019_July.mp3 Iron imaging of substantia nigra in Parkinson's disease: A possible biomarker? 994 No Tue, 06 Aug 2019 00:00:00 EST Is benign hereditary chorea really benign? Dr. Mered Parnes discusses with Dr. Sara Schaefer his article on benign hereditary chorea recently published in the January 2019 issue of the <i>Movement Disorders Clinical Practice</i>. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mdc3.12690/">Read the article</a> Dr. Mered Parnes discusses with Dr. Sara Schaefer his article on benign hereditary chorea recently published in the January 2019 issue of the <i>Movement Disorders Clinical Practice</i>. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mdc3.12690/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/About/MP3-Files/Isbenignhereditarychoreareallybenign__2019_Episode2.mp3 https://www.movementdisorders.org/MDS-Files1/About/MP3-Files/Isbenignhereditarychoreareallybenign__2019_Episode2.mp3 Is benign hereditary chorea really benign? 854 No Wed, 20 Feb 2019 00:00:00 EST Late-stage Parkinsonism: Do we know enough? Dr. Michele Matarazzo interviews Dr. Anette Schrag about the recently published article on late-stage parkinsonism and related neuropsychiatric complications. Why is it important? And are we doing enough to help patients at this stage? <a href=" https://doi.org/10.1002/mdc3.12968/">Read the article</a> Dr. Michele Matarazzo interviews Dr. Anette Schrag about the recently published article on late-stage parkinsonism and related neuropsychiatric complications. Why is it important? And are we doing enough to help patients at this stage? <a href=" https://doi.org/10.1002/mdc3.12968/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/Late-stageparkinsonismdoweknowenough__2020_June.mp3 http://movementdisorders.org/MDS-Files1/Podcasts/Late-stageparkinsonismdoweknowenough__2020_June.mp3 Late-stage Parkinsonism: Do we know enough? 801 No Wed, 08 Jul 2020 00:00:00 EST Long-term outcomes of focused ultrasound in essential tremor Dr. Jin Woo Chang shares the results of 4-year follow-up of MR-guided focused ultrasound thalamotomy in essential tremor. In his article, recently published in the <i>Movement Disorders</i> journal, he analyzes whether the efficacy of this procedure is sustained over time. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.27637/">Read the article</a> Dr. Jin Woo Chang shares the results of 4-year follow-up of MR-guided focused ultrasound thalamotomy in essential tremor. In his article, recently published in the <i>Movement Disorders</i> journal, he analyzes whether the efficacy of this procedure is sustained over time. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.27637/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/About/MP3-Files/LongTermOutcomesofFocusedUltrasoundinEssentialTremor_2019_Episode5.mp3 https://www.movementdisorders.org/MDS-Files1/About/MP3-Files/LongTermOutcomesofFocusedUltrasoundinEssentialTremor_2019_Episode5.mp3 Long-term outcomes of focused ultrasound in essential tremor 1092 No Thu, 06 Jun 2019 00:00:00 EST MDS PSP criteria in practice: From clinical phenotyping to pathological diagnosis Dr. Farwa Ali discusses with Dr. Sara Schaefer the results of her study on the use of the MDS criteria for PSP with the MAX rules and their clinical implications, as well as the challenges of the phenotype variability of this disease in clinical practice and research. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mdc3.12807/">Read the article</a> Dr. Farwa Ali discusses with Dr. Sara Schaefer the results of her study on the use of the MDS criteria for PSP with the MAX rules and their clinical implications, as well as the challenges of the phenotype variability of this disease in clinical practice and research. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mdc3.12807/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSPSPcriteriainpractice_fromclinicalphenotypingtopathologicaldiagnosis_2019_August.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSPSPcriteriainpractice_fromclinicalphenotypingtopathologicaldiagnosis_2019_August.mp3 MDS PSP criteria in practice: From clinical phenotyping to pathological diagnosis 973 No Fri, 30 Aug 2019 00:00:00 EST Neurofilament light chain in Parkinson's disease Dr. Brit Mollenhauer discusses the recent advances in the use of neurofilament light chain for the diagnosis and follow up of Parkinson's disease and related disorders, highlighting the results of a recent longitudinal study. <a href=" https://doi.org/10.1002/mds.28206/">Read the article</a> Dr. Brit Mollenhauer discusses the recent advances in the use of neurofilament light chain for the diagnosis and follow up of Parkinson's disease and related disorders, highlighting the results of a recent longitudinal study. <a href=" https://doi.org/10.1002/mds.28206/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/NeurofilamentlightchaininParkinsonsdisease_2020_November.mp3?version=new https://www.movementdisorders.org/MDS-Files1/Podcasts/NeurofilamentlightchaininParkinsonsdisease_2020_November.mp3?version=new Neurofilament light chain in Parkinson's disease 712 No Fri, 20 Nov 2020 00:00:00 EST Neuroimaging in movement disorders | Congress 2019 As part of the MDS Congress 2019 Special Issue, Dr. Sara Schaefer interviews Dr. Antonio Strafella about the emerging research in neuroimaging in movement disorders and plans to establish a centralized database for neuroimaging in atypical parkinsonisms. As part of the MDS Congress 2019 Special Issue, Dr. Sara Schaefer interviews Dr. Antonio Strafella about the emerging research in neuroimaging in movement disorders and plans to establish a centralized database for neuroimaging in atypical parkinsonisms. https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSCongress2019Imaging.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSCongress2019Imaging.mp3 Neuroimaging in movement disorders | Congress 2019 427 No Thu, 24 Oct 2019 00:00:00 EST Neuroinflammation in Parkinson's disease Dr. Mcihele Matarazzo interviews Dr. David Standaert about the review article he recently published on neuroinflammation in Parkinson's disease, including the main evidence of its role on the pathogenesis of the disease and how understanding it better may help us discovering new therapeutic targets. <a href="https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.28075/">Read the article</a> Dr. Mcihele Matarazzo interviews Dr. David Standaert about the review article he recently published on neuroinflammation in Parkinson's disease, including the main evidence of its role on the pathogenesis of the disease and how understanding it better may help us discovering new therapeutic targets. <a href="https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.28075/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/NeuroinflammationinParkinsonsDiseasewherearewenow__2021_January.mp3?version=new https://www.movementdisorders.org/MDS-Files1/Podcasts/NeuroinflammationinParkinsonsDiseasewherearewenow__2021_January.mp3?version=new Neuroinflammation in Parkinson's disease 490 No Mon, 04 Jan 2021 00:00:00 EST Neuropsychiatric features of punding and hobbyism in Parkinson's disease Dr. Hugo Morales discusses "Neuropsychiatric Features of Punding and Hobbyism in Parkinson’s Disease," by Dr. Pedro Barbosa et al., from <i>Movement Disorders Clinical Practice</i>. <a href="https://movementdisorders.onlinelibrary.wiley.com/doi/epdf/10.1002/mdc3.13363">Read the article.</a> Dr. Hugo Morales discusses "Neuropsychiatric Features of Punding and Hobbyism in Parkinson’s Disease," by Dr. Pedro Barbosa et al., from <i>Movement Disorders Clinical Practice</i>. <a href="https://movementdisorders.onlinelibrary.wiley.com/doi/epdf/10.1002/mdc3.13363">Read the article.</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/mdsPod_ep_54.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/mdsPod_ep_54.mp3 Neuropsychiatric features of punding and hobbyism in Parkinson's disease 1393 No Tue, 15 Feb 2022 00:00:00 EST New technologies in movement disorders | Congress 2019 As part of the MDS Congress 2019 Special Issue, Dr. Matarazzo interviews Dr. Alberto Espay about technology in movement disorders, highlighting recent advances and the goal of the MDS to create a platform that will combine technology-based data and e-diaries. As part of the MDS Congress 2019 Special Issue, Dr. Matarazzo interviews Dr. Alberto Espay about technology in movement disorders, highlighting recent advances and the goal of the MDS to create a platform that will combine technology-based data and e-diaries. https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSCongress2019SpecialIssue_Newtechnologiesinmovementdisorders_2019_October.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSCongress2019SpecialIssue_Newtechnologiesinmovementdisorders_2019_October.mp3 New technologies in movement disorders | Congress 2019 590 No Wed, 06 Nov 2019 00:00:00 EST Overview and core components of the peer review process For the first episode of the special series focused on the peer review process, Dr. Daniel Di Luca speaks with Dr. Christopher Goetz about the importance and most important aspects of a peer review. For the first episode of the special series focused on the peer review process, Dr. Daniel Di Luca speaks with Dr. Christopher Goetz about the importance and most important aspects of a peer review. https://www.movementdisorders.org/MDS-Files1/Podcasts/PodEp55_peerReview1.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/PodEp55_peerReview1.mp3 Special Series: Peer Reviewing Program, Episode 1 Overview and Core Components of the Peer Review 9:15 No Mon, 07 Mar 2022 00:00:00 EST Parkinsonian syndromes and Parkinson's subtypes: Will a single neuroimaging modality ever be enough? Dr. Sara Schaefer speaks with Dr. Nicola Pavese about the imaging modalities currently in use and emerging to differentiate parkinsonian syndromes and Parkinson's subtypes, and how imaging helps us to understand, study, and treat these conditions. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/abs/10.1002/mdc3.13137?af=R/">Read the article</a> Dr. Sara Schaefer speaks with Dr. Nicola Pavese about the imaging modalities currently in use and emerging to differentiate parkinsonian syndromes and Parkinson's subtypes, and how imaging helps us to understand, study, and treat these conditions. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/abs/10.1002/mdc3.13137?af=R/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/ParkinsoniansyndromesandParkinsonssubtypes_Willasingleneuroimagingmodalityeverbeenough__2021_February.m4a?version=new https://www.movementdisorders.org/MDS-Files1/Podcasts/ParkinsoniansyndromesandParkinsonssubtypes_Willasingleneuroimagingmodalityeverbeenough__2021_February.m4a?version=new Parkinsonian syndromes and Parkinson's subtypes: Will a single neuroimaging modality ever be enough? 1096 No Mon, 01 Feb 2021 00:00:00 EST Parkinsonian syndromes and Parkinson's subtypes: Will a single neuroimaging modality ever be enough? Dr. Sara Schaefer speaks with Dr. Nicola Pavese about the imaging modalities currently in use and emerging to differentiate parkinsonian syndromes and Parkinson's subtypes, and how imaging helps us to understand, study, and treat these conditions. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/abs/10.1002/mdc3.13137?af=R/">Read the article</a> Dr. Sara Schaefer speaks with Dr. Nicola Pavese about the imaging modalities currently in use and emerging to differentiate parkinsonian syndromes and Parkinson's subtypes, and how imaging helps us to understand, study, and treat these conditions. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/abs/10.1002/mdc3.13137?af=R/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/ParkinsoniansyndromesandParkinsonssubtypes_Willasingleneuroimagingmodalityeverbeenough__2021_February.m4a https://www.movementdisorders.org/MDS-Files1/Podcasts/ParkinsoniansyndromesandParkinsonssubtypes_Willasingleneuroimagingmodalityeverbeenough__2021_February.m4a Parkinsonian syndromes and Parkinson's subtypes: Will a single neuroimaging modality ever be enough? 18:16 No Wed, 01 Jan 2020 00:00:00 EST Parkinson's disease and Lewy body disorders | Congress 2019 As part of the MDS Congress 2019 Special Issue, Dr. Matarazzo interviews Dr. K. Ray Chaudhuri about news in Parkinson’s disease and Lewy body dementia, including new treatments, scales and other advances in early and late-stage PD. <a href=" /">Read the article</a> As part of the MDS Congress 2019 Special Issue, Dr. Matarazzo interviews Dr. K. Ray Chaudhuri about news in Parkinson’s disease and Lewy body dementia, including new treatments, scales and other advances in early and late-stage PD. <a href=" /">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSCongress2019SpecialIssue_Parkinson_sdiseaseandLewybodydisorders_2019_October.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSCongress2019SpecialIssue_Parkinson_sdiseaseandLewybodydisorders_2019_October.mp3 Parkinson's disease and Lewy body disorders | Congress 2019 7:11 No Wed, 06 Nov 2019 00:00:00 EST Patient vs. care partner assessment of cognitive disability in Parkinson's: Who's more accurate? Benjamin Deck discusses with Dr. Schaefer the article he recently published in the <i>Movement Disorders Clinical Practice</i> on the patient vs. care partner assessment of cognition in Parkinson's disease. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mdc3.12781/">Read the article</a> Benjamin Deck discusses with Dr. Schaefer the article he recently published in the <i>Movement Disorders Clinical Practice</i> on the patient vs. care partner assessment of cognition in Parkinson's disease. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mdc3.12781/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/Patientvs.carepartnerassessmentofcognitivedisability_whosmoreaccurate_.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/Patientvs.carepartnerassessmentofcognitivedisability_whosmoreaccurate_.mp3 Patient vs. care partner assessment of cognitive disability in Parkinson's: Who's more accurate? 1021 No Fri, 28 Jun 2019 00:00:00 EST Perampanel may reduce alpha-synuclein transmission in Parkinson's disease. A possible therapeutic target? Dr. Michele Matarazzo speaks with Prof. Ryosuke Takahashi about the results of his recent study that shows how this anti-epileptic drug may inhibit the transmission of alpha synuclein in PD. While this was tested in animal models, future clinical trials are warranted to test the effects on PD progression. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.28558/">Read the article</a> Dr. Michele Matarazzo speaks with Prof. Ryosuke Takahashi about the results of his recent study that shows how this anti-epileptic drug may inhibit the transmission of alpha synuclein in PD. While this was tested in animal models, future clinical trials are warranted to test the effects on PD progression. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.28558/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/Podcast_Perampanel_may_reduce_alpha-synuclein_transmission.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/Podcast_Perampanel_may_reduce_alpha-synuclein_transmission.mp3 Perampanel may reduce alpha-synuclein transmission in Parkinson's disease. A possible therapeutic target? 866 No Mon, 18 Oct 2021 00:00:00 EST Practicing medicine in time of pandemic and future of Movement Disorders medical practice Dr. Michele Matarazzo interviews Prof. Roy Alcalay on the effects that the COVID-19 pandemic is having on the clinical activity and how it is changing the way we see patients. Will telemedicine be an integrating part of our clinical practice? Dr. Michele Matarazzo interviews Prof. Roy Alcalay on the effects that the COVID-19 pandemic is having on the clinical activity and how it is changing the way we see patients. Will telemedicine be an integrating part of our clinical practice? https://www.movementdisorders.org/MDS-Files1/Podcasts/MovementDisordersintimesofCOVID-19_Practicingmedicineintimeofpandemicandfutureofmovementdisordersmedicalpractice.mp3 https://movementdisorders.org/MDS-Files1/Podcasts/MovementDisordersintimesofCOVID-19_Practicingmedicineintimeofpandemicandfutureofmovementdisordersmedicalpractice.mp3 Practicing medicine in time of pandemic and future of Movement Disorders medical practice 1012 No Tue, 26 May 2020 00:00:00 EST Randomized controlled trial of exercise on objective and subjective sleep in Parkinson's disease Dr. Michele Matarazzo interviews Dr. Amy Amara, the first author of the article awarded as "2020 Research Article from <i>Movement Disorders</i>" on the effects of exercise on sleep in Parkinson's disease. <a href=" https://doi.org/10.1002/mds.28009/">Read the article</a> Dr. Michele Matarazzo interviews Dr. Amy Amara, the first author of the article awarded as "2020 Research Article from <i>Movement Disorders</i>" on the effects of exercise on sleep in Parkinson's disease. <a href=" https://doi.org/10.1002/mds.28009/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/2020ResearchArticleAwardfromtheMovementDisordersJournal_RandomizedControlledTrialofExerciseonObjectiveandSubjectiveSleepinParkinsonsDisease.mp3 https://movementdisorders.org/MDS-Files1/Podcasts/2020ResearchArticleAwardfromtheMovementDisordersJournal_RandomizedControlledTrialofExerciseonObjectiveandSubjectiveSleepinParkinsonsDisease.mp3 2020 research article award from the movement disorders journal | Randomized controlled trial of exercise on objective and subjective sleep in Parkinson's disease 722 No Wed, 14 Oct 2020 00:00:00 EST Rasagiline in PD: Does it change disease progression? And how do we measure it? A recent trial showed no benefit of 1mg rasagiline versus placebo on 1-year progression in an early Parkinson's disease cohort. The investigators used a novel method to track disease progression with MRI, apart from usual clinical standards. Dr. David Vaillancourt shares the results of this trial recently published in the Movement Disorders Journal. <a href="https://doi.org/10.1002/mds.28838"> Read the article.</a> A recent trial showed no benefit of 1mg rasagiline versus placebo on 1-year progression in an early Parkinson's disease cohort. The investigators used a novel method to track disease progression with MRI, apart from usual clinical standards. Dr. David Vaillancourt shares the results of this trial recently published in the Movement Disorders Journal. <a href="https://doi.org/10.1002/mds.28838"> Read the article.</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/Pod-ep-63_rasagiline.mp3 http://www.movementdisorders.org/MDS-Files1/Podcasts/Pod-ep-63_rasagiline.mp3 Rasagiline in PD: Does it change disease progression? And how do we measure it? 15:57 no Mon, 09 May 2022 00:00:00 EST Reviewing case reports and clinical series Dr. Daniel Di Luca discusses how to approach and review case reports and case series in movement disorders with Prof. Kailash Bhatia. Dr. Daniel Di Luca discusses how to approach and review case reports and case series in movement disorders with Prof. Kailash Bhatia. https://www.movementdisorders.org/MDS-Files1/Podcasts/Podep60-PeerReview4.mp3 http://movementdisorders.org/Podcasts/Reviewing-a-case-report-and-clinical-series.htm Reviewing a case report and clinical series 09:57 no Mon, 18 Apr 2022 00:00:00 EST Scar dancing syndrome Dr. Yiwen Wu discusses a newly-described peripherally-induced movement disorder (PIMD), and discusses with Dr. Schaefer the potential pathophysiologies of PIMDs. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/epdf/10.1002/mdc3.13142/">Read the article</a> Dr. Yiwen Wu discusses a newly-described peripherally-induced movement disorder (PIMD), and discusses with Dr. Schaefer the potential pathophysiologies of PIMDs. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/epdf/10.1002/mdc3.13142/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/ScarDancingSyndrome_2021_January.m4a?version=new https://www.movementdisorders.org/MDS-Files1/Podcasts/ScarDancingSyndrome_2021_January.m4a?version=new Scar dancing syndrome 504 No Sat, 09 Jan 2021 00:00:00 EST Swim for Parkinson: Swimming together to improve together The neurologists Dr. Francesca Morgante and Dr. Nicola Modugno and Cecilia Ferrari, a person with Parkinson's disease, share their experience swimming across the strait of Messina, highlighting the importance of physical activity in PD. The neurologists Dr. Francesca Morgante and Dr. Nicola Modugno and Cecilia Ferrari, a person with Parkinson's disease, share their experience swimming across the strait of Messina, highlighting the importance of physical activity in PD. https://www.movementdisorders.org/MDS-Files1/Podcasts/Podcast_SwimforParkinson.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/Podcast_SwimforParkinson.mp3 Swim for Parkinson: Swimming together to improve together 563 No Mon, 18 Oct 2021 00:00:00 EST Tau imaging for the study of corticobasal syndrome: The first steps of in vivo neuropathology Dr. Günter Hoglinger discusses the article he recently published in the <i>Movement Disorders</i> journal on tau imaging in a cohort of corticobasal syndrome patients, along with amyloid PET and CSF analysis to differentiate the neuropathological entity underlying the clinical manifestations. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.28624/">Read the article</a> Dr. Günter Hoglinger discusses the article he recently published in the <i>Movement Disorders</i> journal on tau imaging in a cohort of corticobasal syndrome patients, along with amyloid PET and CSF analysis to differentiate the neuropathological entity underlying the clinical manifestations. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.28624/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/Tauimagingforthestudyofcorticobasalsyndrome_thefirststepsofinvivoneuropathology_2021_September.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/Tauimagingforthestudyofcorticobasalsyndrome_thefirststepsofinvivoneuropathology_2021_September.mp3 Tau imaging for the study of corticobasal syndrome: The first steps of in vivo neuropathology 612 No Mon, 13 Dec 2021 00:00:00 EST The impact of COVID-19 on scientific research activities​ In this interview, Prof. Brit Mollenhauer provides insight into how researchers have been coping with the COVID-19 pandemic. <a href=" https://www.movementdisorders.org/MDS/News/MDS-Community-Conversations/MDS-Community-Conversations-The-Impact-of-COVID-19-on-Scientific-Research-Activities.htm/">Read the article</a> In this interview, Prof. Brit Mollenhauer provides insight into how researchers have been coping with the COVID-19 pandemic. <a href=" https://www.movementdisorders.org/MDS/News/MDS-Community-Conversations/MDS-Community-Conversations-The-Impact-of-COVID-19-on-Scientific-Research-Activities.htm/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/MDS_CC_Podcast2_MollenhauerInterview.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/MDS_CC_Podcast2_MollenhauerInterview.mp3 The impact of COVID-19 on scientific research activities​ 13:50 No Fri, 06 Nov 2020 00:00:00 EST The Mediterranean diet in Parkinson's disease Dr. Nikolaos Scarmeas discusses with Dr. Michele Matarazzo the results of his article about the impact of the Mediterranean diet on the risk of Parkinson’s disease, published in the January 2019 issue of the <i>Movement Disorders</i> journal. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/abs/10.1002/mds.27489/">Read the article</a> Dr. Nikolaos Scarmeas discusses with Dr. Michele Matarazzo the results of his article about the impact of the Mediterranean diet on the risk of Parkinson’s disease, published in the January 2019 issue of the <i>Movement Disorders</i> journal. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/abs/10.1002/mds.27489/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/About/MP3-Files/MediterraneanDietinParkinsonsDisease_2019_Episode1.mp3 https://www.movementdisorders.org/MDS-Files1/About/MP3-Files/MediterraneanDietinParkinsonsDisease_2019_Episode1.mp3 The Mediterranean diet in Parkinson's disease 12:03 No Mon, 11 Feb 2019 00:00:00 EST The most impactful paper related to movement disorders therapy in the 20th century Dr. Sara Schaefer speaks with Dr. Stanley Fahn about the origins of levodopa therapy for Parkinson's disease in the 1960s, how that generated an explosion of interest and research in dopamine's role in movement disorders and beyond, and how it all led to the dawning of the movement disorders field, journal, society, and community that we are all part of today. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mdc3.13337/">Read the article</a> Dr. Sara Schaefer speaks with Dr. Stanley Fahn about the origins of levodopa therapy for Parkinson's disease in the 1960s, how that generated an explosion of interest and research in dopamine's role in movement disorders and beyond, and how it all led to the dawning of the movement disorders field, journal, society, and community that we are all part of today. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mdc3.13337/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/Podcast_Stan_Fahn_Research_of_the_20th_Century.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/Podcast_Stan_Fahn_Research_of_the_20th_Century.mp3 The most impactful paper related to movement disorders therapy in the 20th century 3671 No Mon, 18 Oct 2021 00:00:00 EST The treatment of upper limb tremor with botulinum toxin: An individualized approach Dr. Sara Schaefer discusses with Dr. Jordan Kamel the role of botulinum toxin in the treatment of refractory upper limb tremor, and his center's tailored approach to provide relief for these patients. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mdc3.12832/">Read the article</a> Dr. Sara Schaefer discusses with Dr. Jordan Kamel the role of botulinum toxin in the treatment of refractory upper limb tremor, and his center's tailored approach to provide relief for these patients. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mdc3.12832/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSPodcastOctober2019.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSPodcastOctober2019.mp3 The treatment of upper limb tremor with botulinum toxin: An individualized approach 873 No Fri, 01 Nov 2019 00:00:00 EST Tic disorders and Tourette syndrome | Congress 2019 As part of the MDS Congress 2019 Special Issue, Dr. Michele Matarazzo interviews Dr. Christos Ganos about the newly created MDS Tic Disorders and Tourette Syndrome Study Group, and the main news breakthroughs in the field, that have been discussed during the MDS Congress. As part of the MDS Congress 2019 Special Issue, Dr. Michele Matarazzo interviews Dr. Christos Ganos about the newly created MDS Tic Disorders and Tourette Syndrome Study Group, and the main news breakthroughs in the field, that have been discussed during the MDS Congress. https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSCongress2019SpecialIssue_TicdisordersandTouretteSyndrome_2019_October.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSCongress2019SpecialIssue_TicdisordersandTouretteSyndrome_2019_October.mp3 Tic disorders and Tourette syndrome | Congress 2019 211 No Wed, 06 Nov 2019 00:00:00 EST TikTok tics Dr. Sara Schaefer speaks with Dr. Caroline Olvera about trending videos of tics and other neurological syndromes on social media. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mdc3.13316/">Read the article</a> Dr. Sara Schaefer speaks with Dr. Caroline Olvera about trending videos of tics and other neurological syndromes on social media. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mdc3.13316/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/TikTockTics_August_2021.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/TikTockTics_August_2021.mp3 TikTok tics 1291 No Sun, 01 Aug 2021 00:00:00 EST Tremor | Congress 2019 As part of the MDS Congress 2019 Special Issue, Dr. Michele Matarazzo interviews Dr. Rodger Elble about recent advances in tremor classification, diagnosis and treatment approaches, and about the future plans of the MDS Tremor study group to overcome current challenges for clinicians and researchers. As part of the MDS Congress 2019 Special Issue, Dr. Michele Matarazzo interviews Dr. Rodger Elble about recent advances in tremor classification, diagnosis and treatment approaches, and about the future plans of the MDS Tremor study group to overcome current challenges for clinicians and researchers. https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSCongress2019SpecialIssue_Tremor_2019_October.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/MDSCongress2019SpecialIssue_Tremor_2019_October.mp3 Tremor | Congress 2019 282 No Wed, 06 Nov 2019 00:00:00 EST Unmet needs of women with Parkinson's disease: Gaps and controversies Dr. Sarah Lidstone interviews Dr. Indu Subramanian about her recent paper, "Unmet needs of women with Parkinson's disease: Gaps and Controversies," in <i>Movement Disorders</i>. <a href=" https://doi.org/10.1002/mds.28921">Read the article. </a> Dr. Sarah Lidstone interviews Dr. Indu Subramanian about her recent paper, "Unmet needs of women with Parkinson's disease: Gaps and Controversies," in <i>Movement Disorders</i>. <a href=" https://doi.org/10.1002/mds.28921">Read the article. </a> https://www.movementdisorders.org/MDS-Files1/Podcasts/Pd-65-Unmet-Needs-of-Women-with-PD.mp3 http://www.movementdisorders.org/Podcasts/Unmet-needs-of-women-with-Parkinsons-disease-Gaps-and-controversies.htm Unmet needs of women with Parkinson's disease: Gaps and controversies 25:44 no International Parkinson and Movement Disorder Society Mon, 23 May 2022 00:00:00 EST Value of invivosynuclein deposits in Parkinson's disease - Asystematic review and metaanalysis Dr. Michele Matarazzo interviews Dr. Kazuto Tsukita, the first author of the article awarded as "2020 Review Article from <i>Movement Disorders</i>" on the advances of in-vivo alpha-synuclein detection as a biomarker for Parkinson. <a href=" https://doi.org/10.1002/mds.27794/">Read the article</a> Dr. Michele Matarazzo interviews Dr. Kazuto Tsukita, the first author of the article awarded as "2020 Review Article from <i>Movement Disorders</i>" on the advances of in-vivo alpha-synuclein detection as a biomarker for Parkinson. <a href=" https://doi.org/10.1002/mds.27794/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/2020ReviewArticleAwardfromtheMovementDisordersJournal_ValueofinvivosynucleindepositsinParkinsonsdisease_Asystematicreviewandmetaanalysis.mp3 https://movementdisorders.org/MDS-Files1/Podcasts/2020ReviewArticleAwardfromtheMovementDisordersJournal_ValueofinvivosynucleindepositsinParkinsonsdisease_Asystematicreviewandmetaanalysis.mp3 2020 review article award from the movement disorders journal: Value of invivosynuclein deposits in Parkinson's disease - Asystematic review and metaanalysis 630 No Wed, 14 Oct 2020 00:00:00 EST Variability of movement disorders: The influence of sensation Dr. Michele Matarazzo speaks with Prof. Maja Kojović about the paper awarded as 2021 best review article from the <i>Movement Disorders</i> journal, highlighting the impact on several factors on the variability of movement disorders. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.28415/">Read the article</a> Dr. Michele Matarazzo speaks with Prof. Maja Kojović about the paper awarded as 2021 best review article from the <i>Movement Disorders</i> journal, highlighting the impact on several factors on the variability of movement disorders. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.28415/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/Podcasts/Podcast_Bestreviewarticle.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/Podcast_Bestreviewarticle.mp3 Variability of movement disorders: The influence of sensation 945 No Mon, 18 Oct 2021 00:00:00 EST What are journal editors looking for in a good review? This is the third episode of the special series focused on the peer review process. In this episode, Dr. Alana Kirby speaks with Dr. Jon Stoessl about what journal editors are looking for in a good review. He provides practical tips for writing an effective peer review. This is the third episode of the special series focused on the peer review process. In this episode, Dr. Alana Kirby speaks with Dr. Jon Stoessl about what journal editors are looking for in a good review. He provides practical tips for writing an effective peer review. https://www.movementdisorders.org/MDS-Files1/Podcasts/PodEp58_ReviewSeries3.mp3 https://www.movementdisorders.org/MDS-Files1/Podcasts/PodEp58_ReviewSeries3.mp3 What are journal editors looking for in a good review? 12:26 no Mon, 04 Apr 2022 00:00:00 EST When should dopaminergic treatment be initiated in Parkinson's disease? Dr. Ruth Schneider discusses with Dr. Sara Schaefer about the article she recently published in the <i>Movement Disorders Clinical Practice</i> that investigates the outcomes of early vs delayed start of dopaminergic medication in Parkinson's disease. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mdc3.12724/">Read the article</a> Dr. Ruth Schneider discusses with Dr. Sara Schaefer about the article she recently published in the <i>Movement Disorders Clinical Practice</i> that investigates the outcomes of early vs delayed start of dopaminergic medication in Parkinson's disease. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mdc3.12724/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/About/MP3-Files/WhenshoulddopaminergictreatmentbeinitiatedinParkinsonsdisease__2019_Episode4.mp3 https://www.movementdisorders.org/MDS-Files1/About/MP3-Files/WhenshoulddopaminergictreatmentbeinitiatedinParkinsonsdisease__2019_Episode4.mp3 When should dopaminergic treatment be initiated in Parkinson's disease? 893 No Tue, 30 Apr 2019 00:00:00 EST When to accept or decline an invitation to review For the second episode of the special series focused on the peer review process, Dr. Shweta Prasad speaks with Prof. Günther Deuschl about the crucial first part of the peer review process - identifying reviewers, and understanding when a reviewer should accept or decline an invitation to review. For the second episode of the special series focused on the peer review process, Dr. Shweta Prasad speaks with Prof. Günther Deuschl about the crucial first part of the peer review process - identifying reviewers, and understanding when a reviewer should accept or decline an invitation to review. https://www.movementdisorders.org/MDS-Files1/Podcasts/WhenToAcceptAPeerReview_1.mp3 https://movementdisorders.org/MDS-Files1/Podcasts/WhenToAcceptAPeerReview_1.mp3 When to accept or decline an invitation to review 9:37 No Mon, 21 Mar 2022 00:00:00 EST White matter changes in Huntington's disease Dr. Sara Schaefer discusses with Dr. Sarah Gregory her recent study on neuroimaging changes and fluid biomarkers in Huntington's disease, and how those may be used to better characterize the biological basis for neurodegeneration in this disease <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mdc3.12866/">Read the article</a> Dr. Sara Schaefer discusses with Dr. Sarah Gregory her recent study on neuroimaging changes and fluid biomarkers in Huntington's disease, and how those may be used to better characterize the biological basis for neurodegeneration in this disease <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mdc3.12866/">Read the article</a> https://www.movementdisorders.org/MDS-Files1/About/MP3-Files/WhiteMatterChangesInHuntingtonsDisease.mp3 https://www.movementdisorders.org/MDS-Files1/About/MP3-Files/WhiteMatterChangesInHuntingtonsDisease.mp3 White matter changes in Huntington's disease 1189 No Mon, 20 Jan 2020 00:00:00 EST